Literature DB >> 2768235

A novel peptide, vasoactive intestinal contractor, of a new (endothelin) peptide family. Molecular cloning, expression, and biological activity.

K Saida1, Y Mitsui, N Ishida.   

Abstract

A new peptide family (endothelin (ET] consisting of three members in mammals appears to be present in mice according to genomic Southern blot analysis. Two ET-related genes were identified by cloning and sequence analysis of a mouse genome. One encoded a peptide identical to porcine and human vasoconstrictor peptide ET, and the other encoded a novel peptide differing from ET in 3 amino acid residues, with 4 cysteines in the same positions as in ET. This novel peptide was synthesized and confirmed to have in vivo pressor activity similar to that of ET. Northern blot analysis, however, indicated the gene of this novel peptide to be expressed only in the intestine, and not in other tissues or cell lines, or endothelial cells. Furthermore, the peptide evoked a strong contractile response in the guinea pig ileum. This peptide may thus be reasonably classified as a gastrointestinal peptide, vasoactive intestinal contractor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2768235

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Solution conformation of human big endothelin-1.

Authors:  M L Donlan; F K Brown; P W Jeffs
Journal:  J Biomol NMR       Date:  1992-09       Impact factor: 2.835

2.  Establishment of vascular endothelial cell lines in a serum-free culture and the discovery of endothelin and a Vasoactive Intestinal Contractor (VIC).

Authors:  Y Mitsui; K Saida; N Ishida; T Imamura; M Kobayashi
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

3.  Endothelin-1 mRNA expression in the rat kidney.

Authors:  D J Nunez; E A Taylor; V M Oh; J P Schofield; M J Brown
Journal:  Biochem J       Date:  1991-05-01       Impact factor: 3.857

Review 4.  The vascular endothelin system in hypertension--recent patents and discoveries.

Authors:  Meri M Hynynen; Raouf A Khalil
Journal:  Recent Pat Cardiovasc Drug Discov       Date:  2006-01

5.  Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor.

Authors:  H Y Lin; E H Kaji; G K Winkel; H E Ives; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

Review 6.  Endothelin B receptor, a new target in cancer immune therapy.

Authors:  Lana E Kandalaft; Andrea Facciabene; Ron J Buckanovich; George Coukos
Journal:  Clin Cancer Res       Date:  2009-06-30       Impact factor: 12.531

7.  Endothelin action in rat liver. Receptors, free Ca2+ oscillations, and activation of glycogenolysis.

Authors:  C Serradeil-Le Gal; C Jouneaux; A Sanchez-Bueno; D Raufaste; B Roche; A M Préaux; J P Maffrand; P H Cobbold; J Hanoune; S Lotersztajn
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

8.  Localisation of endothelin like immunoreactivity in adult and developing human gut.

Authors:  C Escrig; A E Bishop; H Inagaki; G Moscoso; K Takahashi; I M Varndell; M A Ghatei; S R Bloom; J M Polak
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

9.  Cross tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin.

Authors:  A C Le Monnier de Gouville; I Cavero
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

10.  Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression.

Authors:  J D Firth; P J Ratcliffe
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.